Pfizer says COVID-19 vaccine more than 90 per cent effective in kids – CTV

October 22, 2021

Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91 per cent effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.

The shots could begin in early November, with the first children in line fully protected by Christmas, if regulators give the go-ahead. That would represent a major expansion of the nation’s vaccine drive, encompassing roughly 28 million elementary school-age youngsters.

Details of Pfizer’s study were posted online. The Food and Drug Administration was expected to post its own review of the company’s safety and effectiveness data later in the day.

Read more: https://www.ctvnews.ca/health/coronavirus/pfizer-says-covid-19-vaccine-more-than-90-per-cent-effective-in-kids-1.5633987

NationTalk Partners & Sponsors Learn More